Fluoroquinolones vs macrolides
Relapse ‐ not reported · patients with Shigella dysentery
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
Findings
What do systematic reviews say?
8 questions · 8 findings · 3 reviews · Infectious Diseases
No studies found 2 · 25%GRADE not reported 2 · 25%Very low 3 · 37.5%Low 1 · 12.5%Moderate 0 · 0%High 0 · 0%
Fluoroquinolones vs beta‐lactams
Relapse · patients with Shigella dysentery
It is very uncertain whether fluoroquinolones changes relapse ‐ All trials clinical criteria compared with beta‐lactams (very low certainty).
1 finding from 1 review
- RR 0.91 [0.11, 7.55]3 studies · 357 participantsVery low
Ceftriaxone vs fluoroquinolones
Relapse · adults and children with enteric fever
It is very uncertain whether ceftriaxone changes relapse compared with fluoroquinolones (very low certainty).
1 finding from 1 review
- Treatment of enteric fever (typhoid and paratyphoid fever) with cephalosporins 2022 · Cochrane Headline outcomes onlyRR 0.95 [0.31, 2.92]3 studies · 297 participantsVery low
Cefixime vs fluoroquinolones
Relapse · adults and children with enteric fever
Cefixime may leads to higher relapse compared with fluoroquinolones (low certainty).
1 finding from 1 review
- Treatment of enteric fever (typhoid and paratyphoid fever) with cephalosporins 2022 · Cochrane Headline outcomes onlyRR 4.45 [1.11, 17.84]2 studies · 220 participantsLow
Fluoroquinolone substitution for isoniazid in a standard six month regimen vs standard regimen
Relapse · Patients with presumed drug‐sensitive TB
1 finding from 1 review
- Fluoroquinolones for treating tuberculosis (presumed drug‐sensitive) 2013 · Cochrane Headline outcomes onlyno estimate extracted0 studies · 0 participantsGRADE not reported
Fluoroquinolone plus standard regimen vs standard regimen
Relapse · Patients with presumed drug‐sensitive TB
1 finding from 1 review
- Fluoroquinolones for treating tuberculosis (presumed drug‐sensitive) 2013 · Cochrane Headline outcomes onlyno estimate extracted0 studies · 0 participantsGRADE not reported
Fluoroquinolone substitution for ethambutol in a standard six month regimen vs standard regimen
Relapse · Patients with presumed drug‐sensitive TB
It is very uncertain whether fluoroquinolone substitution for ethambutol in a standard six month… changes relapse compared with standard regimen (very low certainty).
1 finding from 1 review
- Fluoroquinolones for treating tuberculosis (presumed drug‐sensitive) 2013 · Cochrane Headline outcomes onlyRR 0.71 [0.17, 3.06]1 study · 170 participantsVery low
Cotrimoxazole vs fluoroquinolones
Relapse ‐ not reported · patients with Shigella dysentery
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found